Skip to main content

Table 2 BRG1 is frequently lost in melanomas

From: The chromatin remodelling factor BRG1 is a novel binding partner of the tumor suppressor p16INK4a

 

BRM

p16INK4a

BRG1

Primary

83% (19/23)

21% (5/24)

28% (5/18)

Metastatic

78% (21/27)

19% (4/21)

35% (7/20)

Total

80% (40/50)

20% (9/45)

32% (12/38)

  1. Immunohistological detection of BRG1, p16INK4a and BRM in primary and metastatic melanomas showing the proportion of samples with detectable positive staining.
Back to article page

Molecular Cancer

ISSN: 1476-4598